News | October 30, 2025
Lilly to invest $1.2 billion+ to boost oral medicine manufacturing capacity in US
Company plans to create 100 manufacturing jobs and up to 1,000 construction jobs
Company plans to create 100 manufacturing jobs and up to 1,000 construction jobs
The new CMC Process R&D Center represents a strategic investment in scale, sustainability, and specialization
With this expansion, the overall fermentation capacity of the company has increased from 450 KL to 990 KL
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
Extended lab space for product development, customer demos, and training
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
The 16,000-square-foot expansion enhances DuPont’s global sterile operations
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari and Suzhou
Construction of the plant will commence in 2025 with first production expected to be in 2027
Subscribe To Our Newsletter & Stay Updated
